GlaxoSmithKline Pharmaceuticals Limited — Others, 26-03-2025: Trading Window

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting on 13th May 2025 to approve the audited financial results for the fourth quarter and year ending 31st March 2025. Consequently, the trading window for the company's shares will close from 1st April 2025 and reopen on 16th May 2025. This temporary trading halt serves to ensure compliance with insider trading regulations. Investors should note that this development reflects the company's commitment to transparency and regulatory adherence while potentially impacting trading activity during the closure period, signaling a cautious sentiment in the market.